4//SEC Filing
BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 4
Accession 0000899243-20-022972
CIK 0001157601other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 7:40 PM ET
Size
16.0 KB
Accession
0000899243-20-022972
Insider Transaction Report
Form 4
BAY CITY CAPITAL LLC
Director10% Owner
Transactions
- Sale
Common Stock
2020-08-17$110.73/sh−12,500$1,384,125→ 60,375 total - Sale
Common Stock
2020-08-18$110.03/sh−10,197$1,121,976→ 50,178 total - Sale
Common Stock
2020-08-19$107.64/sh−7,303$786,095→ 42,875 total
Holdings
- 3,729,141(indirect: See Footnotes)
Common Stock
- 81,380(indirect: See Footnotes)
Common Stock
Footnotes (3)
- [F1]Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.
- [F2]The securities are held by Fund IV.
- [F3]The securities are held by Co-Investment IV.
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001333817
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 7:40 PM ET
- Size
- 16.0 KB